Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A particular
chelator , 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word tetraxetan.
Examples
-
"We are pleased that clivatuzumab tetraxetan continues to produce encouraging results in this difficult-to-treat disease, and we look forward to evaluating this compound in randomized clinical trials," remarked Cynthia L. Sullivan, president and CEO of Immunomedics.
Is Immunomedics The Company To Help Save Apple CEO Steve Jobs? | Markets | Minyanville.com 2011
-
The company put out a press release this morning that said repeated cycles of its proprietary antibody, clivatuzumab tetraxetan, extended median overall survival to 11.8 months, which is more than double the 5.4 months patients lives were extended when treated with a single cycle.
Is Immunomedics The Company To Help Save Apple CEO Steve Jobs? | Markets | Minyanville.com 2011
-
Immunomedics, which develops antibody-based products for treatment of cancer, autoimmune and other diseases, said the patient was inadvertently given a higher dose of the drug, clivatuzumab tetraxetan.
-
Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer
THE MEDICAL NEWS 2010
-
Results from the ongoing Phase I/II study of fractionated yttrium-90-labeled clivatuzumab tetraxetan in combination with gemcitabine for patients with inoperable, advanced pancreatic cancer were presented at the 2010 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology.
News 2010
-
Results from the ongoing Phase I/II study of fractionated yttrium-90-labeled clivatuzumab tetraxetan in combination with gemcitabine for patients with inoperable, advanced pancreatic cancer were presented at the 2010 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology.
News 2010
-
Results from the ongoing Phase I/II study of fractionated yttrium-90-labeled clivatuzumab tetraxetan in combination with gemcitabine for patients with inoperable, advanced pancreatic cancer were presented at the 2010 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology.
News 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.